IMNN earnings date and last-quarter result: last quarter beat, P/E -0.27. Updated 2026-07-23.
Imunon (IMNN) Research Hub
Imunon (IMNN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.23 USD (-0.40%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.27, market cap 0.00B. This hub links to the full technical, earnings and options research available for IMNN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.23 USD (-0.40%) |
| 52-week range | 0.96 USD – 2.18 USD |
| Trend regime | Range |
| 14-day RSI | 60.6 (Bullish) |
| Trailing P/E | -0.27 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for IMNN
Covered Call on IMNN: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMNN: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMNN: how it works, illustrative setup around the real 1.23 USD price, max profit/loss, breakeven and when to use it. Educational.
IMNN technical analysis: range, last 1.23 USD, RSI 60.6, 52w range 0.96 USD–2.18 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IMNN in?
Imunon (IMNN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMNN in an uptrend or downtrend?
As of 2026-10-26, IMNN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMNN's trailing P/E ratio?
IMNN's trailing P/E is -0.27, with a market cap of 0.00B. See the earnings research page for full valuation detail.